Australia antigen and antibody and alpha-fetoglobulin in hepatoma patients.
D002759:Adenoma, Bile Duct / Q000276:immunology*; D000328:Adult; D000368:Aged; D000510:Alpha-Globulins / Q000032:analysis*; D000906:Antibodies; D000937:Antigen-Antibody Reactions; D000941:Antigens; D006528:Carcinoma, Hepatocellular / Q000209:etiology / Q000276:immunology*; D005260:Female; D005326:Fetal Proteins / Q000032:analysis*; D006511:Hepatitis B Antigens / Q000032:analysis; D006515:Hepatitis B virus / Q000276:immunology*; D006801:Humans; D007104:Immune Adherence Reaction; D007118:Immunoassay; D007136:Immunoglobulins / Q000032:analysis; D007158:Immunologic Techniques; D008103:Liver Cirrhosis / Q000150:complications; D008113:Liver Neoplasms / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D044469:Racial Groups
D000510:Alpha-Globulins; D000906:Antibodies; D000941:Antigens; D005326:Fetal Proteins; D006511:Hepatitis B Antigens; D007136:Immunoglobulins